查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球美容外科市场 - 2023-2030
市场调查报告书
商品编码
1297766

全球美容外科市场 - 2023-2030

Global Cosmetic Surgery Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概况

全球美容手术市场在2022年达到613亿美元，预计到2030年将见证有利可图的增长，达到1322亿美元。在预测期间（2023-2030年），全球美容整形市场预计将呈现10.4%的复合增长率。进行美容整形手术是为了改变外观。对一些人来说，这意味着重塑身体的轮廓和形态，抚平皱纹，或去除秃头。其他人则选择静脉曲张治疗或隆胸。

美容手术的主要目的是为了提高外观。美容手术的治疗方法、技术和理念完全集中在改善外观上。主要目的是改善视觉吸引力、对称性和比例。美容手术可以在头部、颈部或身体的任何部位进行。美容手术被认为是选择性的，因为它们解决的是功能正常的区域。

市场动态

女性美容手术患者的增加

根据国际美容整形外科协会（ISAPS）的数据，女性美容手术患者的增加可归因于女性对身体外观的关注和新兴经济体人均消费的增加。提供各种服务并拥有尖端技术和项目的医疗水疗中心数量不断增加，进一步支持了这个因素。这些因素促进了市场中女性部分的增长。

对微创外科手术的需求上升

整容手术的主要好处之一是效果通常是持久的或永久的，因为对整容手术的需求增加，它已被更自由地提供，并已建立了许多诊所。

整容手术的这些重要优势导致了市场的扩大。可支配收入的扩大，更多的社会意识，娱乐业对这些治疗的需求扩大，以及需要整形改造的灾难性事故频率的上升，都是市场的驱动力。

美容手术的高成本

在许多新兴和中等收入国家，美容手术已经变得 "不那么容易获得"。这似乎是阻碍市场扩张的主要问题。恢复期往往长达 2-3周，阻碍了市场的发展。

此外，印度的整形手术费用在15,000印度卢比（188美元）到2,50000印度卢比（3,133美元）之间，甚至更高，这取决于所选择的技术、手术中遇到的困难、医院提供的额外服务、咨询和测试。这种令人望而却步的治疗价格可能会扼杀市场的扩张。

COVID-19影响分析

由于封锁预防措施和对选择性手术的限制，许多美容外科诊所和机构在疫情初期不得不暂时停止或减少服务。因此，进行美容治疗的数量大大减少。对感染病毒的恐惧，财务上的不确定性，以及对基本医疗服务的关注，都导致了对美容手术需求的下降。

许多人推迟或取消了选择性手术，以便在整个流行病期间优先考虑他们的健康和安全。例如，2020年的美容整形手术治疗量下降了10.9%，全世界有77.8%的临床医生因COVID-19疫情而临时关闭诊所。非手术程序（主要是填充物和脱毛治疗）增长，尽管速度比前几年慢。因此，总体手术量下降了1.8%。

目录

第一章：方法和范围

  • 研究方法
  • 报告的研究目标和范围

第二章：定义和概述

第三章：执行摘要

  • 按程序抽查
  • 按产品分类
  • 按地区分类

第四章：动态变化

  • 影响因素
    • 驱动因素
      • 女性美容手术患者的增加
      • 对微创外科手术的需求上升
    • 限制因素
      • 美容手术的高成本
    • 机会
      • 自我监测应用程序的引入
    • 影响分析

第五章：行业分析

  • 波特的五力分析
  • 供应链分析
  • 价格分析
  • 监管分析

第六章：COVID-19分析

  • COVID-19的分析
    • COVID-19之前的情况
    • COVID-19期间的情况
    • COVID-19之后的情况
  • 在COVID-19期间的定价动态
  • 需求-供应谱系
  • 大流行期间与市场有关的政府倡议
  • 制造商的战略倡议
  • 结论

第7章：按程序划分

  • 腹部整形术
  • 眼睑整形术
  • 乳房整形术
  • 臀部隆起术
  • 激光嫩肤
  • 面部手术
  • 吸脂术
  • 其他

第8章：按产品分类

  • 植入物
    • 唇部植入物
    • 乳房假体
    • 臀部植入物
    • 下巴和脸颊植入物
  • 设备
    • 脱毛激光器
    • 皮肤重塑激光器
    • 吸脂设备
    • 微型磨皮机
  • 注射器
    • 肉毒杆菌毒素
    • 胶原蛋白
    • 透明质酸

第九章：按地区划分

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美其他地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
  • 中东和非洲

第十章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 合併和收购分析

第十一章 ：公司简介

  • AbbVie
    • 公司概况
    • 产品组合和说明
    • 财务概况
    • 主要发展情况
  • Bausch Health Companies
  • Candela Syneron
  • Cynosure Technologies
  • Galderma SA
  • Johnson and Johnson
  • Merz Pharma GmbH
  • Sientra
  • Sinclair Pharma
  • Teoxane Laboratories

第十二章 ：附录

简介目录
Product Code: MD215

Market Overview

The Global Cosmetic Surgery Market reached US$ 61.3 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 132.2 billion by 2030. The global cosmetic surgery market is expected to exhibit a CAGR of 10.4% during the forecast period (2023-2030). Cosmetic plastic surgery is performed to alter look. For some, it implies reshaping the body's contour and form, smoothing wrinkles, or removing bald spots. Others choose for varicose vein therapy or breast augmentation.

Cosmetic surgery primary principal is focused to enhance the appearance. Cosmetic surgery treatments, techniques, and philosophies are solely focused on improving look. The primary aims are to improve visual appeal, symmetry, and proportion. Aesthetic surgery can be done on any part of the head, neck, or body. Cosmetic operations are considered elective since they address regions that function normally.

Market Dynamics

Rise in Female Cosmetic Surgery Patients

According to the International Society of Aesthetic Plastic Surgery (ISAPS), the increase in female cosmetic surgery patients can be ascribed to females' increased attention on physical appearance and rising per capita spending in emerging economies. This factor is bolstered further by the expanding number of medical spas that provide a variety of services and boast cutting-edge technology and items. These factors contribute to the market's female segment's growth.

Rise In the Demand for Minimally Invasive Surgical Procedures

One of the primary benefits of cosmetic surgery is that the effects are generally long-lasting or permanent because of the increased demand for cosmetic operations, it has been more freely available, and numerous clinics have been established.

These important advantages for cosmetic surgery led to market expansion. Expanding disposable income, more societal awareness, expanding demand for these treatments in the entertainment business, and a rise in the frequency of catastrophic accidents needing reconstructive alterations are all driving drivers for the market.

High Cost of Cosmetic Surgeries

Cosmetic surgery has become 'not so simply accessible' in many emerging and middle-income nations. This appears to be the primary issue impeding market expansion. Recovery period can often be as lengthy as 2-3 weeks, preventing the market from increasing.

Also, plastic surgery in India costs between INR 15,000 ($188) and INR 2,50,000 ($3,133), or even more, depending on the technique chosen, difficulties encountered during the operation, additional services provided by the hospital, consultations, and tests. This prohibitive price of therapy may stifle market expansion.

COVID-19 Impact Analysis

Many cosmetic surgery clinics and organizations had to temporarily stop or reduce their services during the early phases of the epidemic owing to lockdown precautions and limits on elective procedures. As a result, the number of cosmetic treatments performed has decreased significantly. Fear of getting the virus, financial uncertainty, and a focus on basic healthcare services all contributed to a drop in demand for aesthetic operations.

Many people postponed or cancelled elective operations in order to priorities their health and safety throughout the epidemic. The amount of aesthetic plastic surgery treatments, for instance, fell by 10.9% in 2020, with 77.8% of clinicians worldwide experiencing temporary practise closures owing to the COVID-19 epidemic. Nonsurgical procedures (mostly fillers and hair removal treatments) grew, albeit at a slower rate than in previous years. As a result of this, overall operations decreased by 1.8%.

Segment Analysis

The global cosmetic surgery market is segmented based on procedure and product and region.

The Breast augmentation Surgical Procedure Segment Will Account for Approximately 36.7% During the Forecast Period

Breast augmentation remains the most common surgical procedure for women, while surgery to remove implants increased by 22.6 percent, and breast lifts increased by 31.4% in the last year, according to the ISAPS survey. For instance, The International Society of Aesthetic Plastic Surgery (ISAPS) presented the findings of its annual Global Survey on Aesthetic/Cosmetic treatments, which revealed a 19.3% rise in cosmetic surgery treatments.

Geographical Analysis

North America is the Dominating Region During the Forecast Period

North America has the largest share accounting for 40.7% during the forecast period. The size of the market in the area is predicted to grow steadily in the future years. The increased acceptance of cosmetic surgery and widespread knowledge are important driving elements behind the market's expansion. Furthermore, fast improvements in associated technologies like as improved silicone and polymer implants are propelling the region's cosmetic surgery business.

Competitive Landscape

The major global players include: AbbVie, Bausch Health Companies, Candela Syneron, Cynosure Technologies, Galderma SA, Johnson and Johnson, Merz Pharma GmbH, Sientra, Sinclair Pharma, and Teoxane Laboratories.

Why Purchase the Report?

  • To visualize the global cosmetic surgery market segmentation based on the procedures and product and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of global cosmetic surgery market level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global cosmetic surgery market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1 Snippet by Procedures
  • 3.2 Snippet by Product
  • 3.4 Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1 Rise in Female Cosmetic Surgery Patients
      • 4.1.1.2 Rise in the demand for minimally invasive surgical procedures
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost of Cosmetic Surgeries
    • 4.1.3. Opportunity
      • 4.1.3.1The introduction of self-monitoring apps
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's 5 forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of COVID-19
    • 6.1.1. Scenario Before COVID-19
    • 6.1.2. Scenario During COVID-19
    • 6.1.3. Scenario Post COVID-19
  • 6.2. Pricing Dynamics Amid COVID-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturers' Strategic Initiatives
  • 6.6. Conclusion

7. By Procedure

  • 7.1. Abdominoplasty
  • 7.2. Blepharoplasty
  • 7.3. Mammoplasty
  • 7.4. Buttock augmentation
  • 7.5. Laser Skin Rejuvenation
  • 7.6. Face Surgery
  • 7.7. Liposuction
  • 7.8. Other

8. By Product

  • 8.1. Implants
    • 8.1.1. Lip Implants
    • 8.1.2. Breast Implants
    • 8.1.3. Buttock Implants
    • 8.1.4. Chin and Cheek Implants
  • 8.2. Equipment
    • 8.2.1. Hair removal lasers
    • 8.2.2. Dermal resurfacing lasers
    • 8.2.3. Liposuction equipment
    • 8.2.4. Microdermabrators
  • 8.3. Injectables
    • 8.3.1. Botulinum toxin
    • 8.3.2. Collagen
    • 8.3.3. Hyaluronic acid

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.5.1. The U.S.
      • 9.2.5.2. Canada
      • 9.2.5.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.5.1. Germany
      • 9.3.5.2. The UK
      • 9.3.5.3. France
      • 9.3.5.4. Italy
      • 9.3.5.5. Spain
      • 9.3.5.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. Brazil
      • 9.4.5.2. Argentina
      • 9.4.5.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. China
      • 9.5.5.2. India
      • 9.5.5.3. Japan
      • 9.5.5.4. Australia
      • 9.5.5.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Procedure
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AbbVie
    • 11.1.1. Company overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Bausch Health Companies
  • 11.3. Candela Syneron
  • 11.4. Cynosure Technologies
  • 11.5. Galderma SA
  • 11.6. Johnson and Johnson
  • 11.7. Merz Pharma GmbH
  • 11.8. Sientra
  • 11.9. Sinclair Pharma
  • 11.10. Teoxane Laboratories

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us